Nanog dynamics in mouse embryonic stem cells by Marucci, Lucia
                          Marucci, L. (2017). Nanog dynamics in mouse embryonic stem cells. Stem
Cells International, [7160419]. DOI: 10.1155/2017/7160419
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1155/2017/7160419
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via Hindawi at
https://www.hindawi.com/journals/sci/2017/7160419/. Please refer to any applicable terms of use of the
publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms.html
Review Article
Nanog Dynamics in Mouse Embryonic Stem Cells: Results from
Systems Biology Approaches
Lucia Marucci1,2
1Department of Engineering Mathematics, University of Bristol, Bristol BS8 1UB, UK
2BrisSynBio, Life Sciences Building, Tyndall Avenue, Bristol BS8 1TQ, UK
Correspondence should be addressed to Lucia Marucci; lucia.marucci@bristol.ac.uk
Received 7 December 2016; Accepted 20 April 2017; Published 8 June 2017
Academic Editor: Gary E. Lyons
Copyright © 2017 LuciaMarucci. This is an open access article distributed under the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Mouse embryonic stem cells (mESCs), derived from the inner cell mass of the blastocyst, are pluripotent stem cells having self-
renewal capability and the potential of diﬀerentiating into every cell type under the appropriate culture conditions. An
increasing number of reports have been published to uncover the molecular mechanisms that orchestrate pluripotency and cell
fate speciﬁcation using combined computational and experimental methodologies. Here, we review recent systems biology
approaches to describe the causes and functions of gene expression heterogeneity and complex temporal dynamics of
pluripotency markers in mESCs under uniform culture conditions. In particular, we focus on the dynamics of Nanog, a key
regulator of the core pluripotency network and of mESC fate. We summarize the strengths and limitations of diﬀerent
experimental and modeling approaches and discuss how various strategies could be used.
1. Introduction
Pluripotent stem cells are deﬁned by their ability to undergo
self-renewal and capability of diﬀerentiating into all three
germ layers (mesoderm, endoderm, and ectoderm). Even
though during development pluripotency is a temporary
condition, ad hoc cultures can sustain indeﬁnite self-
renewal of cells isolated from the inner cell mass (embryonic
stem cells, ESCs) in vitro [1]. Also, it is now well assessed
that somatic cells can be reprogrammed back to the plurip-
otent state, obtaining the so-called induced pluripotent stem
cells (iPSCs), thus reverting the physiological diﬀerentiation
process [2].
Given the potential of pluripotent cells in regenerative
medicine applications, in the recent years, a big research
eﬀort has been put in understanding the molecular mecha-
nisms behind ESCs decision-making. Outcomes of this
research are crucial to deﬁne optimal culture conditions to
push cells into the desired pluripotent or diﬀerentiated state,
to optimise somatic cell reprogramming, to better under-
stand in vivo development, and to guide the use of repro-
grammed cells for regeneration purposes.
High variability in terms of functionality, gene expres-
sion, and epigenetic signature has been highlighted as a
peculiar feature of both ESCs and iPSCs [3]. Focusing on
gene expression variability in undiﬀerentiated, isogenic
mouse ESCs (mESCs), a number of pluripotency-related
genes have been shown to be expressed heterogeneously
and to present temporal ﬂuctuations in mESCs cultured in
standard serum/leukemia inhibitory factor (LIF) medium.
Nanog, a master regulator of pluripotency and develop-
ment [4–6], was the ﬁrst pluripotency gene for which hetero-
geneity and temporal ﬂuctuations were observed [7, 8]. This
was followed by the discovery of heterogeneous expression of
other pluripotency factors, such as T-box 3 [9], zinc-ﬁnger
protein 42 (also known as Rex1) [10], Klf4 [10], Stella [11],
Esrrb [12], and β-catenin [13]. Importantly, the mosaic and
interconvertible distribution of pluripotency genes often
correlates with diﬀerent degrees of potency; at population
level, mESCs are fully pluripotent, but subpopulations show
a diﬀerent predisposition towards diﬀerentiation.
Alternative media to serum/LIF have been proposed [14].
The so-called 3i/LIF medium is serum free and contains 3
small molecules: PD0325901 (hereafter named PD), a MEK
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inhibitor [15]; SU5402, a FGF receptor inhibitor [16]; and
CHIR99021 (Chiron), a glycogen synthase kinase-3 (Gsk3)
inhibitor [17]. Intriguingly, most pluripotency genes
become overall homogeneous in mESCs cultured in the
3i/LIF medium, even in the absence of FGF inhibitor (i.e.,
in 2i/LIF medium), and the “ground state” of pluripotency
is achieved [14, 18, 19].
Is heterogeneity of Nanog and other pluripotency factors
an inherent property of mESCs, fundamental for their com-
petence to choose diﬀerent fates [20], or is it an impediment
to achieve standardizes cultures [21]? How do heterogeneity
and complex temporal patterns of Nanog originate, and how
do diﬀerent culture media regulate them?
In the recent years, both experimental and computational
studies have tried to address these questions. In vitro cultures
are an artiﬁcial approximation of in vivo systems and self-
renewal is not part of in vivo development; still, the range
of pluripotent states that exists in vitro as a response to diﬀer-
ent culture conditions [1] mimics diﬀerent stages of develop-
ment (preimplantation embryo and late blastocyst for 2i/LIF
and serum/LIF cultures, resp. [22, 23]); thus, experimental
and computational studies of gene expression patterns and
dynamics in both media are relevant.
Notably, many of the metastable mESC genes are,
directly or indirectly, regulated by Nanog [20]; thus, in this
review, we provide an updated overview of the major recent
computational attempts to explain origins and functions of
Nanog dynamics in mESCs, alongside with a review of
available experimental data. We show that mathematical
models can both aid in elucidating the mechanisms behind
complex temporal gene expression dynamics and generate
testable predictions.
We start reviewing works that use small transcriptional
gene regulatory networks (GRNs) to explain Nanog dynam-
ics and their role in mESC fate decision; then, we report
non-GRN approaches; ﬁnally, we discuss open questions in
the ﬁeld and possible future research directions.
2. Dynamics of mESCs Explained through
Transcriptional Regulatory Networks:
Multistable Models for mESC Pluripotency
Notable is the work of Peterson’s group in developing
computational models to understand the role of transcrip-
tion factor dynamics in mESC decision-making. We ﬁrstly
review two early Peterson’s works which consider the
mESC switch between the pluripotent and the diﬀerenti-
ated states a bistable system; Nanog heterogeneity is not
considered, but the basis for formalisms developed later
by the same authors to recapitulate more complex dynam-
ics are given.
In 2006 [24], a nonlinear ordinary diﬀerential equation
(ODE) model, based on the Shea-Ackers formalism [25],
was developed to describe mESC decision-making in view
of the dynamics of the core pluripotency network, formed
by Oct4, Sox2, and Nanog [26]. The topology is composed
of nested positive feedback loops, which respond to environ-
mental signals (inputs) and act on target genes (outputs),
generically indicated as stemness and diﬀerentiation genes.
Oct4 and Sox2 form a heterodimer, which positively regu-
lates both genes and Nanog [27]; also, Nanog activates itself,
Oct4, and Sox2 (Figure 1). The ODE model describing such
network predicts correlated dynamics of Nanog and Oct4-
Sox2. Particular input signals (such as addition of LIF or
Wnt to culture) can switch both on, pushing cells to a plurip-
otent state, while diﬀerent inputs (such as p53) can switch
them oﬀ. The system shows bistability; the pluripotent and
diﬀerentiated steady states are stable and mutually exclusive,
meaning that the system can converge to one of the two,
depending on the initial conditions and inputs. Model analy-
sis highlights a central role of Nanog autoregulation for the
core pluripotency network maintenance.
Also, the model predicts that, if Nanog is high enough,
pluripotency is maintained even in the absence of Oct4
and Sox2 induction by external factors. Intriguingly, this
prediction has been partly conﬁrmed experimentally.
Nanog can compensate for loss of self-renewal genes such
as Esrrb, Tbx3 or Tcl1 [28], and Oct4+/− mESCs lack
Nanog-low, undiﬀerentiated cells [29]. The model presents
some limitations: it is unable to describe an eﬀect of Oct4
overexpression in initiating diﬀerentiation [4, 30, 31],
Nanog heterogeneity in the pluripotency state is not con-
sidered, and noise is neglected.
In 2008, the same authors proposed an extension of
the above model to better recapitulate mESC diﬀerentia-
tion dynamics [32]. While the topology of the core pluri-
potency network is kept identical to the previous work,
two new mutual antagonistic interactions are introduced
to describe diﬀerentiation: Cdx2/Oct4 (responsible for tro-
phectoderm lineage speciﬁcation) [33] and Nanog/Gata6
(responsible for endoderm lineage speciﬁcation) [34]. In
addition, Cdx2 and Gata6 activate the orphan nuclear
receptor germ cell nuclear receptor (Gcnf), a transcrip-
tional repressor of pluripotency genes [35], which in turn
represses Oct4. Finally, in order to account for evidence
of cell tendency to specify towards an endoderm state
when Oct4 is overexpressed [36], Gata6 activation by
Oct4 is considered; this interaction had not been reported
in the literature, so it is inserted as a model hypothesis,
which is needed to recapitulate dynamics (Figure 2). The
authors developed an ODE formalism, similar to the one
in their previous work [24]; the model reproduces the
coexistence of three steady states, corresponding to plurip-
otent, trophectoderm, and endoderm cellular fates. In the
absence of an external factor that forces Oct4 expression,
the cells stay in the pluripotent state; the switch to a
lineage-speciﬁc steady state is possible only by adding such
external factor. The main achievement of this model is its
ability to explain the biphasic response (“bell/inverse bell
shaped”) of TFs as functions of Oct4 (i.e., they can be
expressed in low/high Oct4 ranges or at intermediate
Oct4 levels, only), a mechanism not easy to explain by
intuition. Interestingly, Gata6 activation by Oct4 hypothe-
sized by the authors has been later proved, experimentally,
in early blastocyst development [37]. As in the 2006 model
[24], Nanog is expressed homogeneously in all cells in the
pluripotent state.
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3. Experimental Evidence of Nanog
Heterogeneity in Serum/LIF-Cultured mESCs
In 2005, the ﬁrst experimental evidence of Nanog multi-
modal distribution was reported [7]. Immunoﬂuorescence
experiments showed in serum/LIF-cultured mESCs the coex-
istence of two subpopulations, one positive for both Oct4 and
Nanog and one positive for Oct4 only. In 2007, two diﬀerent
studies conﬁrmed these results and highlighted new features
of Nanog heterogeneity. Singh and colleagues [38], using a
cell line previously developed by Mitsui’s group (β-geo cells,
in which the beta-galactosidase-neomycin fusion gene is
inserted on one allele under the endogenous Nanog pro-
moter [6]), conﬁrmed heterogeneity of Nanog in contrast to
homogeneous Oct4 expression. Analyzing by microarray
the two Nanog subpopulations, a clear pluripotency signa-
ture characterized high Nanog (henceforth called HN) cells,
while low Nanog (henceforth called LN) cells showed pro-
nounced expression of mesodermal genes. Also in 2007,
Chambers and colleagues [8] generated a mESC reporter cell
line for Nanog, named TNGA, obtained by inserting a GFP-
IRES-Puro-pA cassette at the Nanog start codon on one
allele. This study provided evidence of both multimodal
Nanog distribution and its temporal ﬂuctuations between
the two states; at steady state, two distinct (GFP negative
and GFP positive, corresponding to LN and HN, resp.)
subpopulations appeared clearly separated and could inter-
convert in time.
In the following years, a number of additional reporter
cell lines have been generated, and diﬀerent experimental
approaches, including ﬂow cytometry and ﬂuorescence-
activated cell sorting (FACS), time-lapse microscopy,
single-cell sequencing and single-molecule RNA-FISH, have
been used to study Nanog distribution and dynamics at the
levels of both single cells and cell populations [20].
4. An Excitable Model for Nanog Heterogeneity
in mESCs Grown in Serum/LIF
The ﬁrst mathematical model accounting for Nanog hetero-
geneity in mESCs grown in serum/LIF medium was
presented in [39]. Kalmar and colleagues combined experi-
ments and mathematical modeling and proposed that Nanog
dynamics arise from a noise-driven excitable system.
Experiments were performed analyzing Nanog levels
with the mentioned TNGA mESC cell line [8] both at popu-
lation level by FACS and at single-cell level by time-lapse
imaging. Nanog was proved to change dynamically, as sorted
LN and HN mESCs were able to reproduce the original
bimodal distribution, both at population level and at single-
cell level; although with diﬀerent timescales, sorted LN cells
tended to rapidly switch to the HN state (within 24 hours),
while sorted HN cells showed a slower switch oﬀ. At single-
cell level, LN mESCs were able to switch Nanog on in 2-day
time-lapse experiments (time lapses for the HN to LN transi-
tion were not included in the paper). Following these exper-
imental observations, the authors derived a mathematical
model showing that the HN state is stable for the system,
with noise driving sporadic excursions of cells in the LN state.
Oct4-Sox2
Oct4 Sox2
Nanog
Cdx2
Gcnf
Gata6
Figure 2: Extended regulatory network for pluripotency modeled in
[32]. The network includes, in addition to the core pluripotency
factors Oct4, Sox2, and Nanog, Cdx2 and Gata6 to represent
trophectoderm and endoderm commitment through Oct4-Cdx2
and Nanog-Gata6 interactions, respectively, and the nuclear
receptor Gcnf. Green and purple ovals represent pluripotency and
diﬀerentiation genes, respectively.
Oct4 Sox2
Oct4-
Sox2
Nanog
Inputs
(e.g.,Wnt)
Input
(e.g.,
p53)
Outputs
(pluripotency
genes)
Outputs
(differentiation
genes)
Figure 1: Core pluripotency regulatory network modeled in [24].
The core network includes the transcription factors Oct4, Sox2,
and Nanog and the heterodimer Oct4-Sox2. Arrow- and bar-
headed lines represent activation and inhibition, respectively,
among genes (green ovals) and inputs/outputs (grey rectangles).
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The system is excitable, thus highly sensible to perturbations
(transcriptional noise, in this case) beyond a certain noise
threshold. In detail, nonlinear ODEs describe the underlying
GNR network, in which Oct4 and Nanog autoactivate their
own and also each other expression and Oct4 inhibits Nanog,
resulting in an overall negative feedback loop topology
(Figure 3(a)). The authors assumed that Oct4 activates
Nanog to saturated levels (thus this interaction is neglected
in the equations) and only high levels of Oct4 can inhibit
Nanog (a full biological motivation for such negative interac-
tion, crucial for the system dynamics, is left by the authors for
further investigation). The equations, based on Hill-like
kinetics, consider protein dynamics only (mRNA steady-
state assumption); Gaussian noise is added to the Nanog
equation, in order to describe the stochastic excursions from
the unique steady state of the system (HN). The model pre-
dicts that Oct4 is more homogenous in HN than in LN cells;
this prediction is validated experimentally by immunoﬂuo-
rescence in FACS-sorted mESCs. While interesting, this
result is not entirely surprising, taking into account the net-
work topology. Finally, a stochastic model is derived and
simulated using Gillespie’s ﬁrst reaction method. Both
single-cell dynamics and population steady-state distribution
of Nanog are reproduced, showing a good agreement with
experimental data, and indicating that the regulation of occu-
pancy of the two Nanog states is noise driven. The authors
showed that the excitable regime is robust to parameter var-
iations and concluded that Nanog cooperative autoregulation
is crucial for the system’s dynamics.
5. Multistable Models for Nanog Heterogeneity
in mESCs Grown in Serum/LIF
In 2010, Glauche and colleagues proposed an alternative
GRN-based formalism to recapitulate again experimental
data obtained with the TNGA cell line. The modeled GRN
includes Oct4-Sox2 heterodimer autoactivation and its acti-
vation on Nanog; also, as in Kalmar’s model, Nanog autoac-
tivation is considered (Figure 3(b)). This latter positive
feedback loop, for proper parameter choices, can give raise
to bistability. The stochastic diﬀerential equation (SDE)
model, based on Hill kinetics, describes only protein dynam-
ics. At steady state, the Nanog bimodal distribution observed
experimentally in [8, 39] is reproduced; in time course simu-
lations, ﬂuctuations between the two states randomly happen
due to the introduction of Gaussian noise (only in the Nanog
equation). The main diﬀerence with the Kalmar model is
that, in this case, both the LN and HN states are stable, with
noise allowing the switch between them. Altering the noise
changes the transition probability of the two Nanog states
and, consequently, the residence times within each state.
Interestingly, the authors simulate also the redistribution of
TNGA cells upon sorting, performed experimentally in
[39], matching the reestablishment of both populations on
a timescale of circa 10 days. The model is ﬁnally analyzed
to study the eﬀect of Nanog heterogeneity on diﬀerentiation;
the authors also consider an external diﬀerentiation signal,
which inhibits Oct4 and is inhibited by Nanog, generating a
double negative feedback loop. As a result of such loop, only
LN mESCs respond to the diﬀerentiation signal with a
decrease in Oct4-Sox2 complex level, indicating that Nanog
has a “gatekeeper” role in mESC pluripotency maintenance.
Of note, the diﬀerentiation signal is external; thus, no mESC
spontaneous cell diﬀerentiation is conjectured. In the same
paper, the authors also consider an alternative scenario in
which, due to the introduction of a negative feedback loop
through a not speciﬁed gene “X” that is activated by Nanog
and represses it (Figure 3(c)), Nanog shows sustained oscilla-
tions, even in the absence of noise. Notably, such Nanog-
mediated autorepression, hypothesized in the paper for
modeling aims, has been later experimentally proven [40].
While still being able to recapitulate the experimental
steady-state Nanog distribution, the oscillation scenario sig-
niﬁcantly diﬀers in the sorting simulations: while the system
is predicted to continuously shift from one steady state to the
other in the ﬂuctuation case, damped oscillations lead to the
reestablishment of the steady-state distribution in the oscilla-
tion scenario. The same authors, more recently, tested exper-
imentally these two discordant predictions, showing higher
plausibility of the noise-induced bistable dynamics [41].
More recently, Lakatos and colleagues proposed a diﬀer-
ent formalism to describe Nanog dynamics arising from a
bistable system [43]. The authors compared dynamics of ﬁve
GRN topologies compatible with experimental evidence of
interactions in the core pluripotency network. In all the ana-
lyzed GRNs, the genes considered are Oct4, Sox2, and
Nanog; Oct4-Sox2 is a common transcription factor for the
three genes and Nanog activates Sox2 (Figure 4, blue arrows).
In addition, the following interactions are included or not:
Nanog activation on Oct4 (as in earlier Chickarmane’s works
[24, 32]), repression of Oct4 on Nanog, and autoinhibition of
Nanog (experimental evidence in [44] and [40], resp.). Of
note, in all topologies, Nanog autoactivation is neglected.
Quasi-steady-state approximation is used for mRNA levels,
proteins are modeled using ODEs based on the Shea-
Ackers representation for transcriptional regulations, and
variations to parameters are introduced to account for cell-
to-cell diversity. Intriguingly, modeling shows that all the
topologies considered can give rise to bistability, due to the
Oct4-Sox2 autoregulation and dimerization. Due to the feed-
back loop between Nanog and Oct4, original parameter
values predict the coexistence of two steady states for both
Nanog and Oct4, contradicting experimental evidence of
Nanog heterogeneity in contrast to Oct4 homogeneity [45].
However, parameter manipulation can shift nullclines and
reproduce the mentioned experimental data.
The authors also considered an extended topology
(Figure 4, additional interactions indicated with black
arrows), which includes the downstream pluripotency genes
Klf4 and Esrrb (the latter acting as an ampliﬁer [46]), ﬁbro-
blast growth factor (FGF) signaling as an autocrine module,
and a negative feedback through the MAP kinase/ERK kinase
(MEK) cascade [47], which aﬀects the cooperativity of the
Oct4/Sox2-Nanog interaction [48–50]. Of note, FGF and
MEK signaling have been proved experimentally to drive dif-
ferentiation of mESCs, with a potential role in mESC hetero-
geneity [47]. Simulations of this extend topology show that
the system allows the existence of distinct substates of Nanog
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and downstream transcription factors, still within the HN
state; LN mESCs have higher Nanog expression than cells
fully committed to diﬀerentiation, in agreement with
experimental evidence [45]. Noise induces stochastic ﬂuctua-
tions between the multiple steady states: Nanog ﬂuctuates in
phase with Esrrb and Klf4, and in antiphase with FGF5, with
Oct4
Oct4-
Sox2
Nanog
EsrrbKlf4
MAPK
Fgf4
Fgf5
Sox2
Figure 4: Extended regulatory network to describe Nanog multistable dynamics in serum/LIF [43]. Blue and black arrows indicate
interactions of the core and extended network, respectively. The extended network interactions include additional pluripotency genes
(Klf4, Esrrb), and diﬀerentiation signaling pathway (FGF and MAPK) genes.
High Oct4
Low Oct4Oct4 Nanog
Sox2
Oct4-
Sox2
Oct4
Nanog
(a) (b)
Oct4-
Sox2
Sox2Oct4
Nanog X
(c)
Figure 3: Pluripotency regulatory networks to describe excitable, bistable and oscillatory Nanog dynamics in serum/LIF. (a) Regulatory
network proposed in [39] to describe Nanog dynamics in serum/LIF as excitable; additive noise is considered for Nanog and allows the
system to transiently escape the HN stable steady state. (b) and (c) Networks proposed in [42] to reproduce Nanog dynamics as bistable
(b) or oscillatory (c). The noise term, summed to Nanog’s equation, is indispensable to reproduce Nanog heterogeneity and dynamics in
(b) only. In (c), the negative feedback loop between Nanog and a not speciﬁed gene (“X”) can generate oscillatory dynamics.
5Stem Cells International
no signiﬁcant changes in Oct4 levels. Interestingly, multiple
substates of the ON state of Nanog are predicted, suggesting
the coexistence of multiple subpopulations of mESCs,
responding diﬀerently to external signaling and having dif-
ferent pluripotency signature. The authors conﬁrm experi-
mentally that several components of the pluripotency
network present a range of expression levels in mESC sub-
populations, as also previously reported [45].
6. Nanog Dynamics in Serum-Free Cultures
The development of culture conditions that enable mESC
ground state pluripotency (2i/LIF medium) prompted the
development of new mathematical formalisms to understand
the mechanisms behind the overall loss of pluripotency gene
heterogeneity.
In 2012, the Peterson group proposed a novel model
[51] to recapitulate distribution and dynamics of Nanog
in diﬀerent culture conditions (heterogeneity and ﬂuctua-
tions in LIF/bone morphogenetic protein (BMP4), homo-
geneity in 2i/LIF-3i/LIF) and their impact on somatic cell
reprogramming (the BMP4/LIF culture condition was con-
sidered equivalent to serum/LIF [52]). In the network
topology, the authors included Nanog and Oct4 autoacti-
vations, and the activation of Oct4-Sox2 on Nanog
(Figure 5(a)), as in their aforementioned previous works
[24, 32]. In order to represent cells with high Oct4 levels
while low Nanog [39], the previously considered Nanog
activation on Oct4 and Sox2 is now removed. Also, the
network includes a diﬀerentiation gene (loosely indicated
as “G” in Figure 5(a)), which autoactivates itself, is acti-
vated by Oct4-Sox2 and mutually represses Nanog. Impor-
tantly, medium-regulated external factors are included:
LIF/BMP4, which activates Nanog, the FGF4 receptor
signaling, and Gsk3. FGF4 and Gsk3, lumped into a single
variable, inhibit Nanog, are activated by the Oct4-Sox2
complex, and are blocked by 2i/3i medium (Figure 5(a)).
Thus, in the overall topology, Nanog is regulated by a
feed-forward loop including Oct4-Sox2 direct activation
and inhibition via FGF4. An important assumption is that
only when the Oct4-Sox2 heterodimer is bound to Nanog
promoter additional TFs can bind (experimental evidence
in [53]). A nonlinear ODEs model based on the Shea-
Ackers formalism [25] is used, assuming steady-state levels
for mRNA concentrations. To account for stochasticity
originated within the network, the authors also formulated
a master equation, simulated using the Gillespie algorithm.
In BMP4/LIF medium, the system is bistable, and stochas-
tic Nanog ﬂuctuations arise. When Nanog levels are very
low, cells are irreversibly pushed into a diﬀerentiation
state, indicating again that Nanog has a pluripotency gate-
keeper function. Also, the model predicts that suppression
of FGF4/Gsk3 by 2i/3i can push cells into the monostable
state (HN); in single-cell simulations, Nanog ﬂuctuates
around the unique steady state due to noise, but heteroge-
neity at population level is lost. Notably, the Nanog steady
state in 2i/3i is higher than the HN steady state in BMP4/
LIF medium. Of note, the noise is kept at the same level,
both in BMP4/LIF and 2i/3i simulations; although LIF is
not present in the 2i/3i simulations, the stem cell state is
initialized with low “G,” and high Nanog and Oct4-Sox2
levels. Interestingly, the model is also used to predict
somatic cell reprogramming dynamics, performing simula-
tions upon overexpression of Oct4 and Sox2: model pre-
dictions match the experimental observation of the
importance of reprogramming factor dosage for the eﬃ-
ciency of the process [54]. If cells are cultured in 2i, an
increase in reprogramming eﬃciency is predicted, with
synchronous Oct4 and Nanog switch-on dynamics; these
predictions are in agreement with experimental evidence
of an increased eﬃciency in the late reprogramming phase
if partially reprogrammed cells are cultured in 2i/LIF
medium [55, 56].
In 2014, Herberg and colleagues proposed another GRN-
based modeling framework to describe medium-dependent
Nanog dynamics and the resulting mESC pluripotency signa-
ture [57]. The authors extended the network topology mod-
eled in 2010 [42] introducing (i) the pluripotency marker
Rex1 [58], directly activated by both Nanog and the Oct4-
Sox2 heterodimer, in order to reproduce experimental data
generated using the Rex1GFPd2 cell line [59]; (ii) FGF/Erk
signaling, which inhibits Nanog and is activated by Oct4;
and (iii) a phenomenological external diﬀerentiation signal,
which inhibits the Oct4-Sox2 complex and is inhibited by
Nanog, to recapitulate diﬀerentiation dynamics
(Figure 5(b)). Of note, Rex1 is only an output of the system,
as it is not involved in any feedback. Overall, the topology
is comparable to the one modeled by Chickarmane in 2012
[51], but here, spontaneous diﬀerentiation arising from
Nanog heterogeneity is not considered: only the inﬂuence
of the cellular environment is investigated.
Hill-based ODEs are derived for all genes; Gaussian noise
is added to Oct4-Sox2, Nanog, and Rex1 equations; ﬁnally,
steady state for mRNAs is assumed. As in the Chickarmane
et al. 2012 paper, the system presents bistability, abrogated
when culture medium is switched to 2i (LIF is implicitly con-
sidered here). In particular, in serum/LIF (FGF/Erk active),
Nanog shows bistability due to its positive autofeedback loop,
which strength is adjusted in order to have a steady-state dis-
tribution of circa 20% LN and 80% HN cells, as observed in
TNGA experiments [8, 39]; the model can also reproduce
Rex1 distribution measured culturing Rex1GFP2 mESCs. In
time simulations, noise allows the switch between the HN
and LN states, which is predicted to happen in the timescale
of days. Increasing the level on noise results in more frequent
switch and raised proportion of LN cells. Parameters of the
Oct4-Sox2 complex are adjusted to keep its level constantly
high and homogeneous.
When simulating the 2i condition, the block of Erk (due
to the presence of PD in the medium) reduces the inhibition
of Nanog, pushing the system outside the bistability region
into the “ground pluripotency” state, characterized by high
Nanog, Oct4-Sox2, and Rex1 and low FGF/Erk. Of note,
the eﬀect of Chiron in the 2i medium is not considered.
The model is used to predict diﬀerentiation dynamics: after
the ﬁrst 24 hours of 2i withdrawal, Nanog decreases with fast
dynamics, followed by Rex1 and, ultimately, Oct4-Sox2,
matching experimental observations [60]. Experimental data
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in the paper validate model predictions about the asynchro-
nicity of the diﬀerentiation process, possibly due to individ-
ual cell variability arising when the inhibitor is removed
from the medium. A comparison with diﬀerentiation
dynamics of cells cultured in serum/LIF (thus, starting from
bimodal Nanog and Rex1 distribution) is not reported.
7. A Probabilistic Model for Nanog
Multistationary Dynamics
Luo and colleagues [61] proposed an alternative approach to
describe medium-depended Nanog dynamics in mESCs.
Diﬀerently from the above formalisms, the authors did not
rely on a regulatory network, to avoid introducing assump-
tions in case of lacking or contrasting data about underlying
regulations, and possible overparameterization. Instead, they
used a statistical model, based on probability density func-
tions and Gaussian noise. The model has just one variable
(representing Nanog), for which the existence of a stationary
distribution is assumed (represented as a mixture of Gaussian
distributions). Using nested sampling, model parameters are
ﬁtted on novel experimental data presented in the paper: the
authors identify in TNGA mESCs the distribution of Nanog
as a mixture of high, medium, and low (HN, MN, and LN,
resp.) subpopulations. Then, they focus on the MN state,
which is shown by experiments to have the highest dynami-
cal changes. Nanog dynamics are measured in sorted MN
cells replated in diﬀerent culture conditions for four days
(LIF/BMP4, PD only, Chiron only, and 2i/LIF); Nanog distri-
bution shifts towards the HN state in the 2i/LIF condition
and these data are used to validate model predictions about
sorting dynamics. Intriguingly, Chiron widens the LN and
MN states, while PD narrows them. One interesting result
of the ﬁtting is a competitive eﬀect of PD and Chiron: while
the ﬁrst tends to add noise to the system, the second can ﬁlter
noise. The approach used in this paper is deﬁnitively interest-
ing: it allows inferring directly the shape of the potential
function from the data, without a priori knowledge of the
underlying signaling network. The experiments were per-
formed 4 days after the sorting; it could be of interest to
perform both experiments and simulations on a longer time-
scale, to check if the distributions reported in the paper are or
not at steady state.
8. Nanog Heterogeneity Arising from Allelic
Switching
Miyanari and Torres-Padilla [62] recently suggested an alter-
native mechanism contributing to Nanog heterogeneity
based on allelic regulation. The authors ﬁrstly analyzed
Nanog nascent transcription by RNA ﬂuorescent in situ
hybridization (RNA-FISH) in vivo, observing monoallelic
and biallelic expression in preimplantation embryo and in
late blastocyst, respectively. To study the dynamic switch of
Nanog in vitro, the authors generated a novel reporter cell
line based on a dual-reporter system (named NGR mESCs),
in which two distinct ﬂuorescent reporters (destabilized Tur-
boGFP and mCherry) are inserted downstream of the
NANOG-coding region in the two alleles. In NGR mESCs
cultured in serum/LIF, Nanog transcriptional ﬁring was
observed, with an odd distribution of allelic ﬁring: only a very
low percentage of cells showed Nanog biallelic expression, in
G
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Sox2
Nanog
LIF/
BMP4
2i/3i
FGF4
Gsk3
Yext
Yin
Oct4-
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Nanog
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FGF4
Erk
2i/3i
(a) (b)
Figure 5: Regulatory network to recapitulate Nanog dynamics in 2i/LIF. Networks proposed and modeled in [51] (a) and [57] (b). Both
systems include Nanog, the Oct4-Sox2 heterodimer, a module for FGF signaling, and the eﬀect of the medium (2i/3i) on network
regulations. In addition, in [51] (a), the interactions with LIF/BMP4 and a diﬀerentiation gene (“G”) are included, while Herberg and
colleagues (b) include Rex1 as a system output only and a diﬀerentiation signal (“Y,” similar to “G” in (a)). In both models, the eﬀects of
the two inhibitors in 2i are lumped.
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contrast to biallelic expression of other pluripotency genes
such as Oct4. Consequently, in vitro cultures showed distinct
populations for Nanog: monoallelic, biallelic, and no expres-
sion; similar results were obtained using single-molecule
RNA-FISH (smRNA-FISH) [63]. In contrast, biallelic
expression was reported in 2i/LIF. These results suggested a
crucial role of allelic expression, and the possibility of achiev-
ing ground state pluripotency by activating the second
Nanog allele.
In light of such results, Wu and Tzanakakis proposed a
mathematical model to recapitulate medium-dependent
Nanog dynamics [64]. The mESC population is divided into
4 groups (biallaleic, monoallelic, and both alleles inactive),
with percentages of residence in each group and probabilities
of transition among groups extrapolated from RNA-FISH
and allele-speciﬁc RT-PCR experiments in [62] (Figure 6).
The stochastic allelic switching is modeled using a homo-
geneous Markov chain, assuming that the next state does
solely depend on the current state; asynchronous prolifera-
tion rates are considered.
The model is simulated using a Monte Carlo algorithm,
setting the half-life of endogenous Nanog to 2 hours, as mea-
sured in [65]. In the absence of noise, at population level,
Nanog distribution shows 3 peaks (low for both alleles inac-
tive, middle for monoallelic, and high for biallelic cells), while
addition of noise leads to a bimodal distribution (LN and HN
only). In single-cell-simulated dynamics, HN cells show a
slow (circa 20 hours) switch oﬀ, while LN cells switch on in
circa 5 hours. The predicted dynamics are much faster than
the ones previously observed with TNGA mESCs; thus, the
authors simulate the expected output of the latter cells, in
which the reporter is inserted only in one allele and has
half-life longer than endogenous Nanog. In this case, even
in the absence of transcriptional noise, only 2 peaks in the
reporter distribution are predicted, conﬁrming experimental
observations in [8, 39]. Also, the predicted correlation
between endogenous Nanog and the reporter dynamics is
very high (Pearson coeﬃcient = 1) if both alleles are tagged
and the half-life of the reporter is comparable to the one of
Nanog, while correlation is lost (Pearson coeﬃcient = 0.06)
using a TNGA-like tagging approach. Finally, the authors
use the model to simulate dynamics of Nanog+/− cells, pre-
dicting that Nanog deletion on one allele can impact its dis-
tribution at population level. The paper does not include
results about Nanog dynamics in 2i/LIF, but the authors
mention that the model could easily be extended to describe
the latter case by properly changing the proportion of cells in
each subpopulation. Simulation results about the impact of
diﬀerences between endogenous and reporter kinetics could
explain mismatches in steady-state distributions and dynam-
ics observed using diﬀerent Nanog-tagged cell lines. Such
predictions have been partly corroborated recently: the group
of Henrique generated a novel reporter cell line (Nd mESCs),
which contains a transgenic bacterial artiﬁcial chromosome
(BAC) with a destabilized Venus reporter protein (Venus-
Nuclear-PEST) under the control of Nanog regulatory
regions [66]. NdmESCs diﬀer from TNGA cells for two main
reasons: the two endogenous Nanog alleles are kept intact
and the half-lives of the reporter mRNA and protein are
comparable to the endogenous Nanog ones (circa 4 and 2
hours, resp.). In NdmESCs grown in serum/LIF, as compared
to TNGA cells, Nanog expression is again mosaic but within
an overall narrower distribution; also, ﬂuctuations between
the LN and the HN state and restoration of the original distri-
bution from LN- and HN-sorted cells occur in a shorter
timescale (circa 4 hours and 2–4 days of culture, resp. [66]).
9. Nanog Dynamics Arising from a Protein
Interaction Network
Recently, Muñoz-Descalzo and colleagues [67] considered an
alternative model to describe Nanog dynamics in mESCs
focusing on posttranscriptional interactions. In view of recent
data generated by the same research group about the key role
of protein balance for mESC pluripotency maintenance [68],
the authors reanalyzed the excitablemodel of Kalmar and col-
leagues and pointed out its failure in reproducing (i) the
increased correlation between Oct4 and Nanog observed by
single-cell immunoﬂuorescences in 2i/LIF medium and (ii)
a critical region characterized by low levels of both Nanog
and Oct4, in which pluripotency is lost. The authors started
considering a minimal model, named NOC (Figure 7(a)),
which encompasses only Oct4 and Nanog, and assume that
the correlation between the two proteins results from the for-
mation of a protein complex (O:N) previously described
experimentally [69–71]. In the model, Oct4 and Nanog pro-
teins exist either free or bound together in a complex;
transcriptional regulations are neglected. Importantly, the
model takes into account diﬀerent stabilities for proteins
(high for Oct4 and Nanog/Oct4 complex and low for Nanog),
measured experimentally in the paper. To account for
transcriptional heterogeneity of Nanog, its transcriptional
bursting [40, 62] is considered. The resulting discrete
stochastic formalism is simulated for both serum/LIF and
2i/LIF conditions by tuning Nanog expression (infrequent
transcriptional bursting in serum/LIF and high frequency
bursting in 2i/LIF). The model correctly matches Nanog
and Oct4 correlation in the two media, and Nanog mRNA
distribution (unimodal in both media, but shifted towards
Biallelic
12% 9%
14%
10%
2%
Mono
allelic
Mono
allelic
Both
alleles
inactive
Figure 6: Schematic of Nanog allelic expression, as modeled in [64].
mESCs are grouped into 4 types given diﬀerent patterns of Nanog
allelic expression; the percentage fraction of mESCs residing in
each group is indicated as well as the transition probability (in
percentage).
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high levels in 2i/LIF) observed experimentally by mRNA-
FISH. Still, the model has some pitfalls: it predicts that
knock-out of Nanog results in increased Oct4 levels, the latter
experimentally associated with diﬀerentiation, contradicting
experimental evidence about mESC ability to maintain plur-
ipotency even in absence of Nanog [8].
Thus, the authors developed a reﬁned model (named
TBON), which also includes Tcf3 and β-catenin, two Wnt
pathway proteins associated with pluripotency [59, 72, 73]
and involved in a protein-complex with Oct4 [74, 75]. The
new topology (Figure 7(b)) considers, in addition to the
Oct4-Nanog complex (O:N), the inducers (PD and Chiron)
and three additional complexes: β-catenin with Oct4 (β:O)
[74, 75], β-catenin with Tcf3 (β:T) [76], and β-catenin with
Oct4 and Nanog (β:O:N).
Stochastic simulations of the model match protein distri-
butions and correlations of protein levels in both serum/LIF
and2i/LIF. Themodel shows that, in 2i/LIF, ground state plur-
ipotency is achieved by attenuation of free Oct4, thus limiting
its eﬀect in promoting diﬀerentiation.Also, themodel predicts
that, in absence of Nanog, the β:O complex becomes stronger,
enabling cells tomaintainpluripotency, as conﬁrmed inexper-
iments reported in the paper. In case of lack of β-catenin, the
model predicts that the correlation between Nanog and Oct4
is unchanged, but their levels are lower, due to Tcf3 increase.
These model predictions are in agreement with experimental
evidence about the not absolute requirement of β-catenin for
pluripotency [77], although its lackmakesmESCsmore prone
to diﬀerentiate [59]. Conversely, abrogation of Tcf3 sustains
pluripotency through increased Nanog, decreased Oct4 and
β-catenin, and impaired Oct4-Nanog correlation. Finally,
the model predicts that the removal of Oct4 from the system
causes a drop in Nanog levels (as, if not bound in protein
complex, Nanog has faster degradation), in agreement with
loss of pluripotency in Oct4−/− cells [31].
10. Limitations of Existing Formalisms for
Ground State Pluripotency Cultures
All the reviewed models but the Muñoz-Descalzo et al. one
just consider the molecular eﬀect of the MEK inhibitor
(PD), neglecting eﬀects of the Gsk3 inhibitor (Chiron) in
ground state pluripotency cultures. Given the failure of PD
alone in sustaining mESC clonal propagation [1, 59] and
the crucial functions of the Wnt/β-catenin pathway in pluri-
potency maintenance and successful reprogramming of
somatic cells to pluripotency [13, 78–82], the role of the
Wnt pathway in cellular heterogeneity and mESC plasticity
should be better characterized. Also, possible eﬀects of non-
homogenous, or cell density-dependent, drug uptake in cel-
lular cultures on the system dynamics might be considered.
Finally, no current model accounts for a certain level of
Nanog heterogeneity and temporal ﬂuctuations persistent
in 2i/LIF recently observed experimentally [83, 84]. It
remains to be shown whether long-term cultures in 2i/LIF
could impair mESC karyotypic and epigenetic stability, given
prolonged exposure of cells to Gsk3 inhibition [85]. Recently,
R2i, an alternative serum-free, chemical media, has been pro-
posed to sustain mESC ground state pluripotency [86]. Of
note, also R2i eliminates mESC heterogeneity, but it acts on
the pluripotency circuit through other routes (it contains
inhibitors of TGFβ and FGF signaling pathways); this pro-
vides a good indication that mosaic expression of pluripo-
tency genes in serum/LIF might originate from multiple
sources, which mathematical formalisms should consider.
11. Crosstalk between Gene Expression
Dynamics and the Cell Cycle
Mathematical models could be particular useful in elucidat-
ing the complex interconnection between cell cycle, the
pluripotency network, and cellular fate. In the experimental
works mentioned in this review, ﬂuctuations of Nanog
reporter genes were observed within a mESC cell cycle [62,
84]; however, there is also evidence of coupling between
pluripotency network gene dynamics and the cell cycle, as
recently reviewed in [87]. In an early work reporting Nanog
heterogeneity [38], FACS-sorted HN cells were found to
upregulate cell cycle genes characteristic of the S-G2 phases,
while LN cells expressed genes characteristic of the G1 phase.
Also, MacArthur and colleagues, using an inducible system,
found a correlation betweenNanog and cell cycle checkpoints
Oct4
O:N
Nanog
훽-cat
훽:T 훽:O
Nanog
O:N
훽:O:N
Chiron PD
Tcf3 Oct4
(a) (b)
Figure 7: Pluripotency protein interaction networks, as modeled in [67]. Scheme of the minimal (a) and reﬁned (b) protein interaction
networks. O:N, β:T, β:O, and β:O:N indicate Oct4-Nanog, β-catenin-Tcf3, β-catenin-Oct4, and β-catenin-Oct4-Nanog complexes,
respectively.
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genes [60]. Recently, Nanog but not Oct4 expression was
proved to oscillate in mESCs synchronized for the cell cycle
[88]. In a recent work [41], Herberg and colleagues extended
their previous GRN model [57] to include mESC prolifera-
tion; the resulting agent-based model predicts an eﬀect of dif-
ferent cell cycle times in the proportion of cells in low-high
Nanog subpopulations in serum/LIF; analysis in ground state
pluripotency cultures (in which mESC cell cycle is known to
diﬀer [89]) was not performed.
Multiscale modeling approaches, able to account simulta-
neously for processes at subcellular, intercellular, and popu-
lation levels, could be highly informed by quantitative
single-cell measurements (such as live imaging and sequenc-
ing), and be able not only to reproduce experimental data but
also to generate useful predictions, usable for targeted control
of mESC fate, both in pluripotency maintenance and in
diﬀerentiation.
12. Conclusions and Future Perspectives
Here, we have reviewed recent computational/experimental
results about mechanisms and consequences of Nanog
dynamics in populations of isogenic mESCs. We reported
main assumptions, results and predictions of mathematical
models based on regulatory networks (in which Nanog
dynamics result from its interactions with other pluripotency
genes, signaling pathways, and drugs at transcriptional and
posttranslational levels [39, 42, 43, 51, 57, 67]), statistical
models [61], and unbalanced Nanog allelic expression [64].
A common conclusion is that Nanog acts as a molecular
gatekeeper, ﬁne-controlling cell fate in response to pluri-
potency and diﬀerentiation genes’ regulations, internal
noise, and external stimuli. We showed that diﬀerent
formalisms are able to reproduce Nanog dynamics
observed experimentally with reporter mESCs cultured in
both serum/LIF and chemical, serum-free culture media,
and generate testable predictions.
Still, many open questions remain regarding both discor-
dant experimental results and the validity of modeling
assumptions. How canmodels based on diﬀerent GRN topol-
ogies reproduce the same experimental data? One critical
step in deriving mathematical models is parameterization.
Notably, given the same system of equations, diﬀerent set
of parameters and timescales of the variables involved can
result in completely diﬀerent dynamic scenarios; conversely,
diﬀerent sets of genes can be included in GRNs to reproduce
speciﬁc dynamics, as far as the topology encompasses key ele-
ments (e.g., positive feedback loop(s) for bistability). It is
therefore crucial, as far as possible, to use parameters directly
measured and rely only on interactions unambiguously
identiﬁed experimentally.
Also, when comparing simulations to experimental data,
it is vital to critically account for the experimental settings
and the timescales of the considered variables. Among the
models reviewed here, only Wu and Tzanakakis explicitly
took into account the diﬀerences in the degradation rates of
endogenous Nanog and its reporter; their results suggest
modeling as a powerful tool for experimentalists to infer
endogenous dynamics from ﬂuorescent reporter data. The
Wu and Tzanakakis paper, as the Luo and colleagues one,
is for sure interesting also for being able to describe Nanog
dynamics at population level starting from single-cell
dynamics, without relying on a GRN model with consequent
assumptions on the network topology. However, the Luo
et al. model, while capable of reproducing Nanog heterogene-
ity, cannot explain its source.
Focusing on timescales, the commonly used steady-state
assumption for mRNA dynamics, while reducing the param-
eter space, might lead to misrepresentative results. Indeed, in
2014, two independent reports [90, 91] focused on Nanog
distribution at the protein level and found that mESCs cul-
tured in serum/LIF do not show protein biallelic expression,
in contrast with mRNA ﬁring measured in [62]. In particular,
in [91], Filipczyk and colleagues generated mESCs encoding
dual fusion proteins to the Nanog C-terminus, with green
and red ﬂuorescent reporters placed on the two alleles. At cell
population level, FACS analysis showed bimodal distribution
for Nanog in mESCs cultured in serum/LIF, although with a
narrower expression range as compared to TNGA cells (as
with Nd cells), but correlated expression of the two fusion
proteins, suggesting biallelic expression of Nanog protein.
These results are in agreement with examination of mature
cytoplasmic RNA transcript, which was found to be biallelic
regardless allelic Nanog ﬁring [63]. Given that the fusion
ﬂuorescent proteins generated by Filipczyk and colleagues
have an half-life comparable to the endogenus Nanog’s one,
protein biallelic expression can be compatible with the
mRNA allelic switching reported in [62] only if diﬀerent
timescales for mRNA and protein are considered [20]. Taken
together, these results suggest that the quasi-steady-state
assumption for Nanog mRNA dynamics might be revised
and that GNR feedback mechanisms are still needed to
explain heterogeneous Nanog protein dynamics in serum/
LIF.
Also, in our view, the impact of intrinsic and extrinsic
noise on mESC fate should be better addressed: molecular
instability is often represented incorporating a stochastic
term in a set of diﬀerential equations, but whether it is a good
representation has not been addressed. It would be extremely
interesting to combine quantitative estimate of noise (as in
[92]) with GRN-based formalisms.
Scaling up the reviewed mathematical models for small
GRNs, involving other key genes involved in pluripotency
and diﬀerentiation identiﬁed with bioinformatics and statis-
tical methods [60, 93–95] and unraveling their role in mESC
temporal dynamics, remains an open challenge. Also, the
descriptive and predictive power of mathematical models
could be signiﬁcantly increased accounting also for the com-
bined role of noncoding RNAs [96–99], epigenetic mecha-
nisms [100], metabolism [101], and posttranscriptional
modiﬁcations [102].
From a more broad prospective, we do believe that the
questions about the role of heterogeneity in mESC
decision-making stated at the beginning of this review have
not yet been fully addressed. Xenopoulos et al. [103], using
high-resolution live cell imaging, reported “salt and pepper”
Nanog pattern in early blastocyst, but lack of temporal ﬂuctu-
ations, and irreversible commitment to epiblast and
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primitive endoderm. If and how heterogeneity can be advan-
tageous for mESC plasticity is currently not known; the prin-
ciples behind the use of noise and ﬂuctuations by genetic
circuits, also in an evolutionary prospective, are beginning
to be elucidated only recently [104]. The hypothesis that
pluripotency is an emergent property of a population of cells
rather than a characteristic of a single cell [60], with noise
and cellular heterogeneity conferring stem cell high entropy,
and thus the potential to choose a number of specialized,
diﬀerentiated fates [105, 106], still needs to be more exten-
sively characterized not only for embryonic but also induced
and adult stem cells. Also, the “exploratory hypothesis” for
pluripotent cells, which conjectures stem cell decision-
making as a two-step process in which ﬁrstly stochasticity
induces a critical state that primes diverse transcriptional
programs, and then one particular fate is chosen via interac-
tion with external inputs [107, 108], represents, in our view,
an interesting research avenue for further investigation.
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